Back
Perspective Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
34
CATX
Perspective Therapeutics
Last Price:
$2.3300
Seasonality Move:
0.1%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.41 | Sell |
| 20-day SMA: | 2.26 | Buy |
| 50-day SMA: | 2.3 | Buy |
| 200-day SMA: | 7.13 | Sell |
| 8-day EMA: | 2.37 | Sell |
| 20-day EMA: | 2.31 | Buy |
| 50-day EMA: | 2.48 | Sell |
| 200-day EMA: | 5.52 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 51.78 | Buy |
| Chaikin Money Flow: | -235510 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.9116 - 2.4316) | Buy |
| Bollinger Bands (100): | (2.2114 - 3.3514) | Sell |
Perspective Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.3500 while CATX 8-day simple moving average is 2.4088, which is a Sell signal.
-
The stock price of CATX is 2.3500 while Perspective Therapeutics 20-day SMA is 2.2610, which makes it a Buy.
-
Perspective Therapeutics 50-day simple moving average is 2.2982 while CATX share price is 2.3500, making it a Buy technically.
-
CATX stock price is 2.3500 and Perspective Therapeutics 200-day simple moving average is 7.1264, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
34
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a SellThe current Perspective Therapeutics [CATX] share price is $2.3500. The Score for CATX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
174M
Price in USD:
2.3500
Share Volume:
364K
Perspective Therapeutics 52-Week Range
52-Week High:
19.0500
52-Week Low:
1.6000
Sell
34
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?The Perspective Therapeutics stock price is 2.3500 USD today.
-
Will CATX stock go up or go down?Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Perspective Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.3500 while CATX 8-day exponential moving average is 2.3720, which is a Sell signal.
-
The stock price of CATX is 2.3500 while Perspective Therapeutics 20-day EMA is 2.3094, which makes it a Buy.
-
Perspective Therapeutics 50-day exponential moving average is 2.4822 while CATX share price is 2.3500, making it a Sell technically.
-
CATX stock price is 2.3500 and Perspective Therapeutics 200-day simple moving average is 5.5170, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.37 per share, and a decrease next year of $0.20 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
-
CATX Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Perspective Therapeutics is a Buy
-
Perspective Therapeutics Relative Strength Index (RSI) is 51.78, which suggest Perspective Therapeutics is overbought
-
The Bollinger Bands (25) for Perspective Therapeutics is (1.9116 - 2.4316), which suggest Perspective Therapeutics is a Sell
-
The Bollinger Bands (100) for Perspective Therapeutics is (2.2114 - 3.3514), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.